Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection. [artículo]
Por: Alcázar de la Ossa, José María [Nefrología]
.
Colaborador(es): Servicio de Nefrología.
Tipo de material: 
ArtículoEditor: Journal of clinical microbiology, 2014Descripción: 52(8):3053-6.Recursos en línea: Solicitar documento Resumen: Amplification of hepatitis C virus (HCV) RNA from blood detected occult HCV infections in 30.9% of 210 HCV-seronegative dialysis patients with abnormal liver enzyme levels that had evaded standard HCV testing practices. Isolated HCV core-specific antibody detection identified three additional anti-HCV screening-negative patients lacking HCV RNA amplification in blood who were considered potentially infectious. Together, these findings may affect management of the dialysis setting.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC16338 (Navegar estantería) | Disponible |
Formato Vancouver:
Barril G, Quiroga JA, Arenas MD, Espinosa M, García-Fernández N, Cigarrán S et al. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection. J Clin Microbiol. 2014 Aug;52(8):3053-6.
PMID: 24850345
PMC4136170
Contiene 15 referencias
Amplification of hepatitis C virus (HCV) RNA from blood detected occult HCV infections in 30.9% of 210 HCV-seronegative dialysis patients with abnormal liver enzyme levels that had evaded standard HCV testing practices. Isolated HCV core-specific antibody detection identified three additional anti-HCV screening-negative patients lacking HCV RNA amplification in blood who were considered potentially infectious. Together, these findings may affect management of the dialysis setting.
No hay comentarios para este ejemplar.